DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
GOCOVRI ( DrugBank: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
6
パーキンソン病
1
6. パーキンソン病
臨床試験数
:
2,307
/
薬物数
:
2,007
- (
DrugBank
:
349
) /
標的遺伝子数
:
188
-
標的パスウェイ数
:
199
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT04387773
(
ClinicalTrials.gov
)
November 5, 2020
11/5/2020
Effect of
GOCOVRI
(Amantadine, Extended Release Capsules) on Gait in Parkinson's Disease
Effect of
GOCOVRI
on Quantity and Quality of Gait in Parkinson's Disease
Parkinson Disease
Drug:
GOCOVRI
Oregon Health and Science University
Adamas Pharmaceuticals, Inc.
Completed
50 Years
80 Years
All
8
Phase 4
United States